MARKET

BWV

BWV

Blue Water Vaccines Inc.
NASDAQ
1.742
+0.022
+1.28%
Opening 14:44 09/30 EDT
OPEN
1.710
PREV CLOSE
1.720
HIGH
1.760
LOW
1.690
VOLUME
73.81K
TURNOVER
88.74K
52 WEEK HIGH
90.90
52 WEEK LOW
1.680
MARKET CAP
23.94M
P/E (TTM)
-1.8588
1D
5D
1M
3M
1Y
5Y
'Ohio reports state's first death from monkeypox, raising U.S. death toll to 3' -BNO Report
https://twitter.com/BNOFeed/status/1575847127166713860
Benzinga · 14h ago
U.S. CDC Director Walensky Says U.S. Moving To Pre-exposure Prophylaxis Strategy For Monkeypox Vaccine
- Reuters 
Benzinga · 2d ago
Blue Water Vaccines to Present at World Vaccine Congress Europe 2022
CINCINNATI, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Blue Water Vaccines Inc. (“BWV” or “Blue Water Vaccines” or the “Company”), a biopharmaceutical company developing transformational vaccines to address significant global health challenges, today announced tha...
GlobeNewswire · 09/21 12:00
European Union Drug Regulator European Medicines Agency Says Monkeypox Infection Trend Gives Hope That The Outbreak Can Be Contained
- Reuters 
Benzinga · 09/20 13:45
Earlier Announced: China Records First Monkeypox Case
The infected patient, who had arrived in Chongqing from overseas, developed symptoms while in Covid quarantine China has been on high alert for the disease since it started spreading rapidly in Europe and the Americas
Benzinga · 09/16 14:51
U.S. CDC Director Says U.S. Monkeypox Cases Are About 23000 As Of Sept 14, There Is Decline In Growth Of New Cases; There Are Some Areas In U.S. Still Seeing Rise In Monkeypox Cases
- Reuters  
Benzinga · 09/15 14:52
White House Says New Monkeypox Cases Down 50% Since Early August
- Reuters 
Benzinga · 09/15 14:45
'Los Angeles Is Investigating The Death Of A Person Who Had Monkeypox' - CNBC
https://www.cnbc.com/2022/09/09/los-angeles-is-investigating-the-death-of-a-person-who-had-monkeypox.html?utm_term=Autofeed&utm_medium=Social&utm_content=Main&utm_source=Twitter#Echobox=1662735758 Los
Benzinga · 09/09 15:04
More
About BWV
Blue Water Vaccines, Inc. is a biotechnology company. It is focused on the research and development of transformational vaccines to prevent infectious diseases worldwide. Its vaccine platform has molecular properties that enables delivery of various antigens, which can be utilized to develop singular or multi-targeted vaccines. Its lead influenza (flu) vaccine program uses technology to identify specific epitopes, or proteins, with cross-reactive properties that enables the development of a universal flu vaccine. It is focused on developing novel vaccines that induce durable and long-term immunity. It is also utilizing its platform to develop a vaccine for the prevention of gastroenteritis cause by both norovirus and rotavirus. Its vaccine candidates include BWV-101 and BWV-102, an influenza vaccine program; BWV-201, which is a streptococcus pneumoniae (S. pneumoniae) vaccine program; BWV-301, a norovirus-rotavirus vaccine program, and BWV-302, a norovirus-malaria vaccine program.

Webull offers kinds of Blue Water Vaccines Inc stock information, including NASDAQ:BWV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BWV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading BWV stock methods without spending real money on the virtual paper trading platform.